Baird Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.2M | Sell |
|
|||||
|
2025
Q2 | $58M | Sell |
|
|||||
|
2025
Q1 | $71M | Sell |
|
|||||
|
2024
Q4 | $79.3M | Sell |
|
|||||
|
2024
Q3 | $96.3M | Buy |
|
|||||
|
2024
Q2 | $89.6M | Sell |
|
|||||
|
2024
Q1 | $181M | Buy |
|
|||||
|
2023
Q4 | $177M | Sell |
|
|||||
|
2023
Q3 | $235M | Sell |
|
|||||
|
2023
Q2 | $267M | Sell |
|
|||||
|
2023
Q1 | $341M | Buy |
|
|||||
|
2022
Q4 | $418M | Buy |
|
|||||
|
2022
Q3 | $302M | Buy |
|
|||||
|
2022
Q2 | $362M | Buy |
|
|||||
|
2022
Q1 | $355M | Sell |
|
|||||
|
2021
Q4 | $418M | Buy |
|
|||||
|
2021
Q3 | $304M | Buy |
|
|||||
|
2021
Q2 | $269M | Buy |
|
|||||
|
2021
Q1 | $247M | Buy |
|
|||||
|
2020
Q4 | $244M | Sell |
|
|||||
|
2020
Q3 | $233M | Buy |
|
|||||
|
2020
Q2 | $202M | Buy |
|
|||||
|
2020
Q1 | $189M | Buy |
|
|||||
|
2019
Q4 | $202M | Sell |
|
|||||
|
2019
Q3 | $186M | Sell |
|
|||||
|
2019
Q2 | $233M | Buy |
|
|||||
|
2019
Q1 | $80.7M | Buy |
|
|||||
|
2018
Q4 | $72.9M | Buy |
|
|||||
|
2018
Q3 | $70.8M | Sell |
|
|||||
|
2018
Q2 | $59.6M | Sell |
|
|||||
|
2018
Q1 | $63.2M | Buy |
|
|||||
|
2017
Q4 | $61.8M | Buy |
|
|||||
|
2017
Q3 | $58.7M | Sell |
|
|||||
|
2017
Q2 | $56.5M | Buy |
|
|||||
|
2017
Q1 | $53.7M | Buy |
|
|||||
|
2016
Q4 | $50.4M | Buy |
|
|||||
|
2016
Q3 | $47.6M | Buy |
|
|||||
|
2016
Q2 | $47.7M | Sell |
|
|||||
|
2016
Q1 | $39.9M | Buy |
|
|||||
|
2015
Q4 | $38.1M | Buy |
|
|||||
|
2015
Q3 | $36.5M | Buy |
|
|||||
|
2015
Q2 | $38.2M | Buy |
|